Literature DB >> 30344648

A magnetic resonance imaging-based prediction model for prostate biopsy risk stratification.

Brian L Meyerson1, Justin Streicher2, Abhinav Sidana2.   

Abstract

Year:  2018        PMID： 30344648      PMCID： PMC6180384          DOI： 10.1177/1756287218788812

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN： 1756-2872


× No keyword cloud information.
  7 in total

1.  Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.

Authors:  Jan Philipp Radtke; Manuel Wiesenfarth; Claudia Kesch; Martin T Freitag; Celine D Alt; Kamil Celik; Florian Distler; Wilfried Roth; Kathrin Wieczorek; Christian Stock; Stefan Duensing; Matthias C Roethke; Dogu Teber; Heinz-Peter Schlemmer; Markus Hohenfellner; David Bonekamp; Boris A Hadaschik
Journal:  Eur Urol       Date:  2017-04-08       Impact factor: 20.096

Review 2.  Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.

Authors:  Matthew J Watson; Arvin K George; Mahir Maruf; Thomas P Frye; Akhil Muthigi; Michael Kongnyuy; Subin G Valayil; Peter A Pinto
Journal:  Future Oncol       Date:  2016-07-12       Impact factor: 3.404

3.  Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy.

Authors:  Akhil Muthigi; Arvin K George; Abhinav Sidana; Michael Kongnyuy; Richard Simon; Vanessa Moreno; Maria J Merino; Peter L Choyke; Baris Turkbey; Bradford J Wood; Peter A Pinto
Journal:  J Urol       Date:  2016-08-28       Impact factor: 7.450

4.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Authors:  M Minhaj Siddiqui; Soroush Rais-Bahrami; Baris Turkbey; Arvin K George; Jason Rothwax; Nabeel Shakir; Chinonyerem Okoro; Dima Raskolnikov; Howard L Parnes; W Marston Linehan; Maria J Merino; Richard M Simon; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  JAMA       Date:  2015-01-27       Impact factor: 56.272

5.  A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification.

Authors:  Sherif Mehralivand; Joanna H Shih; Soroush Rais-Bahrami; Aytekin Oto; Sandra Bednarova; Jeffrey W Nix; John V Thomas; Jennifer B Gordetsky; Sonia Gaur; Stephanie A Harmon; Mohummad Minhaj Siddiqui; Maria J Merino; Howard L Parnes; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  JAMA Oncol       Date:  2018-05-01       Impact factor: 31.777

6.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

7.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.